AU2003283508A1 - .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof - Google Patents
.pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereofInfo
- Publication number
- AU2003283508A1 AU2003283508A1 AU2003283508A AU2003283508A AU2003283508A1 AU 2003283508 A1 AU2003283508 A1 AU 2003283508A1 AU 2003283508 A AU2003283508 A AU 2003283508A AU 2003283508 A AU2003283508 A AU 2003283508A AU 2003283508 A1 AU2003283508 A1 AU 2003283508A1
- Authority
- AU
- Australia
- Prior art keywords
- thanspgreater
- thansbgreater
- thandless
- than4less
- spgreater
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR02/12614 | 2002-10-10 | ||
FR0212614A FR2845604A1 (en) | 2002-10-10 | 2002-10-10 | Use of cDNA encoding a mutant 5-HT4 receptor for treatment or prevention of diseases associated with dysfunctional synthesis of cyclic adenosine monophosphate, e.g. neurodegeneration or asthma |
PCT/FR2003/003002 WO2004033498A2 (en) | 2002-10-10 | 2003-10-10 | .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003283508A8 AU2003283508A8 (en) | 2004-05-04 |
AU2003283508A1 true AU2003283508A1 (en) | 2004-05-04 |
Family
ID=32039620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003283508A Abandoned AU2003283508A1 (en) | 2002-10-10 | 2003-10-10 | .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003283508A1 (en) |
FR (1) | FR2845604A1 (en) |
WO (1) | WO2004033498A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005004865A1 (en) * | 2003-07-08 | 2005-01-20 | Georg-August-Universität Göttingen | Use of 5-ht4(a)-serotonin receptor agonists |
WO2007048846A1 (en) * | 2005-10-27 | 2007-05-03 | Neuraxo Biopharmaceuticals Gmbh | Use of iron-chelating compounds, cyclic adenosine monophosphate-increasing compounds or combinations thereof for treating axonal lesions in the cns |
-
2002
- 2002-10-10 FR FR0212614A patent/FR2845604A1/en active Pending
-
2003
- 2003-10-10 AU AU2003283508A patent/AU2003283508A1/en not_active Abandoned
- 2003-10-10 WO PCT/FR2003/003002 patent/WO2004033498A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2845604A1 (en) | 2004-04-16 |
AU2003283508A8 (en) | 2004-05-04 |
WO2004033498A3 (en) | 2004-07-22 |
WO2004033498A2 (en) | 2004-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003289641A1 (en) | The novel coumarin-amide derivatives and its preparation, said drug composition and its use | |
EP1587474A3 (en) | Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses | |
AU2003262262A1 (en) | Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof | |
HK1167332A1 (en) | Pharmaceutical composition, use thereof and method for making the same | |
AU2003291103A1 (en) | Pharmaceutical composition | |
HUP0500610A3 (en) | Indazoles, benzothiazoles, and benzoisothiazoles, pharmaceutical compositions comprises thereof and their uses | |
AU2003210001A1 (en) | Medicament delivery device | |
AU2003299849A1 (en) | Drug delivery apparatus | |
AU2003289440A1 (en) | Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof | |
IL174479A (en) | Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof | |
AU2003216934A1 (en) | Benzoxazinone derivatives, the preparation and use thereof as medicaments | |
AU2003250372A1 (en) | Pharmaceutical composition | |
AU2003255645A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
EP1831240B8 (en) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
PL394604A1 (en) | Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition | |
AU2002364468A1 (en) | Solid orally-dispersible pharmaceutical formulation | |
AU2003269018A1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
AU2003218359A1 (en) | Polymer composition and dosage forms comprising the same | |
EP1556056A4 (en) | X-nitro compounds, pharmaceutical compositions thereof and uses therof | |
PL374761A1 (en) | N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them | |
AU2003284460A1 (en) | Medicinal composition | |
HK1074444A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
AU2003291758A1 (en) | Waxy matrix dosage forms | |
AU2003280799A1 (en) | Medicinal composition | |
AU2003283508A1 (en) | .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |